The government’s top vaccine official working under Health Secretary Robert F. Kennedy Jr. recently restricted the approval ...

FDA vaccine head Vinay Prasad restricted Moderna and Novavax COVID vaccines to high-risk groups, overriding staff advice amid ...

Recent vaccination announcements have led to some confusion. Four physicians weigh in on who should get vaccinated and when ...

The new Nimbus COVID‑19 variant is on the rise and is known for its startling sore‑throat symptom dubbed “razor blade throat.

In its discussions for the upcoming 2025-2026 respiratory virus season, the COVID vaccination workgroup of the Advisory ...

Two new Omicron subvariants are gaining ground in the U.S. as some people report experiencing respiratory symptoms like ...

After years of updates on COVID-19 vaccines and boosters, it can be confusing to know who should get a shot and when. While a lot of that confusion has to do with the new COVID strains that ...

Cases of the recently identified Covid-19 variant NB 1.8.1. are rising. Some have dubbed the variant "razor blade throat" for ...

There was a decline in hospitalizations and in-hospital mortality due to COVID-19 between 2023 and 2024, a period spanning the XBB, JN.1, and KP eras.

In patients with COVID-19, preexisting immunity and Omicron infection were associated with reduced disease severity and upper respiratory symptom presentation.

Investigators concluded that individuals with comorbidities experienced higher risks of severe COVID-19 outcomes during the ...

As far as health department officials know, they plan to offer COVID vaccines again during the 2025-26 influenza and COVID season, Fedak continued. The 2024-25 COVID vaccine is available at all CVS ...